168 related articles for article (PubMed ID: 14966781)
1. A comment on COMET: how to interpret a positive trial?
Massie BM
J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
[No Abstract] [Full Text] [Related]
2. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
Bristow MR; Feldman AM; Adams KF; Goldstein S
J Card Fail; 2003 Dec; 9(6):444-53. PubMed ID: 14966783
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
Cleland JG
Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
[TBL] [Abstract][Full Text] [Related]
4. [A fairer comparison between carvedilol and metoprolol is still to be done].
Johnsson G; Aberg J
Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
[No Abstract] [Full Text] [Related]
5. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
Swedberg K
Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
[No Abstract] [Full Text] [Related]
6. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
7. The COMET trial.
Bristow MR; Adams KF; Bauman JL; Feldman AM; Giles TD; Goldstein S; Mann DL; Talbert RL
Congest Heart Fail; 2005; 11(1):39-47. PubMed ID: 15722669
[No Abstract] [Full Text] [Related]
8. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.
Shepherd AM
J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784
[No Abstract] [Full Text] [Related]
9. Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray JJ
Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
[No Abstract] [Full Text] [Related]
10. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
Ertl G; Nitschmann S
Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
[No Abstract] [Full Text] [Related]
11. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
Packer M
J Card Fail; 2003 Dec; 9(6):429-43. PubMed ID: 14966782
[TBL] [Abstract][Full Text] [Related]
12. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
13. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
14. [Beta blockers for therapy of chronic heart failure].
Murakami T
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
[No Abstract] [Full Text] [Related]
15. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
Di Lenarda A; Sabbadini G; Sinagra G
Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
[No Abstract] [Full Text] [Related]
16. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
Bauman JL; Talbert RL
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
[TBL] [Abstract][Full Text] [Related]
18. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
19. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
Doggrell SA
Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
[TBL] [Abstract][Full Text] [Related]
20. How should COMET influence heart failure practice?
Adams KF
Curr Heart Fail Rep; 2004 Jul; 1(2):67-71. PubMed ID: 16036027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]